NCT05294302 Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
| NCT ID | NCT05294302 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nemours Children's Clinic |
| Condition | Pediatric Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 350 participants |
| Start Date | 2023-04-14 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 350 participants in total. It began in 2023-04-14 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) with study endpoints focused on decreasing negative psychosocial sequelae (acute distress, posttraumatic stress, and anxiety) and improving coping abilities (coping self-efficacy, cognitive coping strategies). The long-term goal of this research program is to sustain and disseminate an effective, scalable, high-reach, and cost-effective intervention to provide crucial support to PCCC across the pediatric cancer trajectory.
Eligibility Criteria
Inclusion Criteria: * Participants must be the parent or primary caregiver of a child (ages 0 - 18 years old) diagnosed with cancer. * Participants must be able to speak and read English or Spanish. * Participants must have access to the internet through a computer or mobile device (e.g., smartphone, tablet). Exclusion Criteria: * PCCC are ineligible to participate if their child is not expected to live longer than six months from the time of potential recruitment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05294302 clinical trial?
This trial is open to participants of all sexes, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05294302 currently recruiting?
Yes, NCT05294302 is actively recruiting participants. Contact the research team at kimberly.canter@nemours.org for enrollment information.
Where is the NCT05294302 trial being conducted?
This trial is being conducted at Los Angeles, United States, Wilmington, United States, Houston, United States.
Who is sponsoring the NCT05294302 clinical trial?
NCT05294302 is sponsored by Nemours Children's Clinic. The trial plans to enroll 350 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.